Protein detail

AT2B4

Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)

Protein symbol
AT2B4
UniProt ID
EVMP score
0.50
Frequency
2
Transmembrane count
10
Protein classification
EnzymesFDA approved drug targetsMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Basic Information
Protein Names
Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)
Protein Class
EnzymesFDA approved drug targetsMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function
  • Predicted intracellular proteins
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • FDA approved drug targets:Small molecule drugs
Transmembrane
93..113; Helical; 151..171; Helical; 357..376; Helical; 410..427; Helical; 841..860; Helical; 871..891; Helical; 912..934; Helical; 953..974; Helical; 994..1015; Helical; 1026..1047; Helical
Transmembrane Count
10
Entrez Gene Symbol
Gene Synonym
ATP2B2MXRA1PMCA4
Gene Description
ATPase plasma membrane Ca2+ transporting 4
Chromosome
1
Position
203626832-203744081
Frequency
2
EVMP Score
0.50
Fluorescence & Localization
Tissue SpecificlungBrain Regional SpecificcerebellumCell SpecificAlveolar cells type 1Single-Nuclei Brain Specificchoroid plexus epithelial cell
Function & Pathway
Protein Function
  • Predicted intracellular proteins
  • Enzymes
  • ENZYME proteins
  • Transporters:Primary Active Transporters
  • FDA approved drug targets:Small molecule drugs
Canonical Pathways
  • M20 Pid p38 mkk3 6pathway
  • M269 Pid ras pathway
  • M161 Pid ifng pathway
Mediation Categories
Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

3 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
ATP2B4PTK2Q05397Y1,176phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPSIGNORKEAPhosphoSiteSIGNOR:12540962KEA:12540962KEA:9182531
ATP2B4SRCP12931Y1,176phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPHPRDKEAHPRD:9182531KEA:12540962KEA:9182531HPRD:12540962
ATP2B2PRKCAP17252T1,094phosphorylationKEAKEA:1827443

Ligand-Receptor Signaling

44 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo
transportertransporterSurfaceomeNoYesNoNoNo
p_atpasetransporterSurfaceomeNoYesNoNoNo
activetransporterSurfaceomeNoYesNoNoNo
transportertransporterOmniPathNoYesNoNoNo
transmembranetransmembraneUniProt_locationNoNoNoNoNo
transmembranetransmembraneUniProt_topologyNoNoNoNoNo
transmembranetransmembraneUniProt_keywordNoNoNoNoNo
Page 1 of 5Next

Regulatory Interaction Network

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
FAK1Q05397AT2B4P23634YesYesNophosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetSIGNORProtMapperPhosphoSite_KEAKEASIGNOR_ProtMapperPhosphoSitePhosphoSite:12540962ProtMapper:12540962SIGNOR:12540962KEA:9182531PhosphoSite:25847233KEA:12540962

Protein Complex Composition

3 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
ATP2B2HSD17B6O14756Q018140:0hu.MAP
ATP2B4CALM1P0DP23P236341:1PDBPDB:2kne
ATP2B2SFT2D3Q01814Q587I90:0hu.MAP2

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry [LTQ-FT Ultra]Mass spectrometry137713494
Sequence, Structure & Domains

Sequences

Length
1,241
Mass
137,920
Sequence
MTNPSDRVLPANSMAESREGDFGCTVMELRKLMELRSRDALTQINVHYGGVQNLCSRLKTSPVEGLSGNPADLEKRRQVFGHNVIPPKKPKTFLELVWEALQDVTLIILEIAAIISLVLSFYRPAGEENELCGQVATTPEDENEAQAGWIEGAAILFSVIIVVLVTAFNDWSKEKQFRGLQCRIEQEQKFSIIRNGQLIQLPVAEIVVGDIAQVKYGDLLPADGILIQGNDLKIDESSLTGESDHVKKSLDKDPMLLSGTHVMEGSGRMVVTAVGVNSQTGIILTLLGVNEDDEGEKKKKGKKQGVPENRNKAKTQDGVALEIQPLNSQEGIDNEEKDKKAVKVPKKEKSVLQGKLTRLAVQIGKAGLLMSALTVFILILYFVIDNFVINRRPWLPECTPIYIQYFVKFFIIGITVLVVAVPEGLPLAVTISLAYSVKKMMKDNNLVRHLDACETMGNATAICSDKTGTLTMNRMTVVQAYIGGIHYRQIPSPDVFLPKVLDLIVNGISINSAYTSKILPPEKEGGLPRQVGNKTECALLGFVTDLKQDYQAVRNEVPEEKLYKVYTFNSVRKSMSTVIRNPNGGFRMYSKGASEIILRKCNRILDRKGEAVPFKNKDRDDMVRTVIEPMACDGLRTICIAYRDFDDTEPSWDNENEILTELTCIAVVGIEDPVRPEVPDAIAKCKQAGITVRMVTGDNINTARAIATKCGILTPGDDFLCLEGKEFNRLIRNEKGEVEQEKLDKIWPKLRVLARSSPTDKHTLVKGIIDSTVGEHRQVVAVTGDGTNDGPALKKADVGFAMGIAGTDVAKEASDIILTDDNFTSIVKAVMWGRNVYDSISKFLQFQLTVNVVAVIVAFTGACITQDSPLKAVQMLWVNLIMDTFASLALATEPPTESLLKRRPYGRNKPLISRTMMKNILGHAFYQLIVIFILVFAGEKFFDIDSGRKAPLHSPPSQHYTIVFNTFVLMQLFNEINSRKIHGEKNVFSGIYRNIIFCSVVLGTFICQIFIVEFGGKPFSCTSLSLSQWLWCLFIGIGELLWGQFISAIPTRSLKFLKEAGHGTTKEEITKDAEGLDEIDHAEMELRRGQILWFRGLNRIQTQIDVINTFQTGASFKGVLRRQNMGQHLDVKLVPSSSYIKVVKAFHSSLHESIQKPYNQKSIHSFMTHPEFAIEEELPRTPLLDEEEEENPDKASKFGTRVLLLDGEVTPYANTNNNAVDCNQVQLPQSDSSLQSLETSV
Alternative Products
Event=Alternative splicing; Named isoforms=8; Comment=There is a combination of two alternatively spliced domains at N-terminal site A (X and Z) and at C-terminal site B/C (A, B, D and K). The splice sites have mostly been studied independently. Full isoforms so far detected are isoform XA and isoform XB. Experimental confirmation may be lacking for some isoforms.; Name=XD; Synonyms=AIICIV; IsoId=P23634-1; Sequence=Displayed; Name=XA; Synonyms=AIICII; IsoId=P23634-2; Sequence=VSP_000405; Name=ZA; Synonyms=AICII; IsoId=P23634-3; Sequence=VSP_000402, VSP_000405; Name=XK; Synonyms=XG; IsoId=P23634-4; Sequence=VSP_000403, VSP_000405; Name=ZK; Synonyms=ZG; IsoId=P23634-5; Sequence=VSP_000402, VSP_000403, VSP_000405; Name=XB; Synonyms=AIICI, hPMCA4b; IsoId=P23634-6; Sequence=VSP_000404; Name=ZB; Synonyms=AICI; IsoId=P23634-7; Sequence=VSP_000402, VSP_000404; Name=ZD; Synonyms=AICIV; IsoId=P23634-8; Sequence=VSP_000402
Alternative Sequence
301..312; Missing (in isoform ZA, isoform ZK, isoform ZB and isoform ZD); 1009..1044; Missing (in isoform XK and isoform ZK); 1104..1139; Missing (in isoform XB and isoform ZB); 1140..1241; IKVVKAFHSSLHESIQKPYNQKSIHSFMTHPEFAIEEELPRTPLLDEEEEENPDKASKFGTRVLLLDGEVTPYANTNNNAVDCNQVQLPQSDSSLQSLETSV -> VAVAPVKSSPTTSVPAVSSPPMGNQSGQSVP (in isoform XA, isoform XK, isoform ZA and isoform ZK)

3D Structural Models

Turn
1087..1089; 1090..1092
Helix
1093..1102
3D Structure
NMR spectroscopy (2)

Domain & Motif Annotations

Region
294..318; Disordered; 1086..1103; Calmodulin-binding subdomain A; 1104..1113; Calmodulin-binding subdomain B
Protein Families
  • Cation transport ATPase (P-type) (TC 3.A.3) family
  • Type IIB subfamily
Sequence Similarities
Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type IIB subfamily.
Clinical Relevance
Disease Involvement
FDA approved drug targets
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000198668
Interaction Count
1
Interaction Dataset
biogrid_opencell